Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
China flag China · Delayed Price · Currency is CNY
18.95
-0.09 (-0.47%)
Feb 13, 2026, 3:00 PM CST

SHA:605369 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,1091,100955.611,4591,188819.51
Other Revenue
15.0215.0219.479.255.8510.14
1,1241,115975.081,4691,194829.65
Revenue Growth (YoY)
2.35%14.37%-33.61%22.98%43.95%50.03%
Cost of Revenue
785.33752.09661.42894.14668.83439.12
Gross Profit
338.94363.12313.66574.54525.42390.53
Selling, General & Admin
162.66141.21148.2162.48120.4374.88
Research & Development
54.3253.0547.8172.3558.2936.98
Other Operating Expenses
11.0410.178.5112.897.716.15
Operating Expenses
232.35208.95204.17250.32189.4121.04
Operating Income
106.59154.18109.49324.22336.02269.49
Interest Expense
-6.7-2.87-1.45-0.04-0.03-
Interest & Investment Income
21.4530.9917.6715.0120.634.22
Currency Exchange Gain (Loss)
5.975.97-5.3929.65-5.45-13.64
Other Non Operating Income (Expenses)
-5.16-0.28-0.23-0.41-1.53-0.27
EBT Excluding Unusual Items
122.14187.98120.09368.43349.64259.8
Impairment of Goodwill
-1.24-1.24-0.91---
Gain (Loss) on Sale of Investments
-4.544.07--1.83-0.35
Gain (Loss) on Sale of Assets
0.15-0.02-0.01-0.19.19-1.01
Asset Writedown
-4.49--1.69-1.48-2.29-
Other Unusual Items
-2.31-2.061.745.664.23.28
Pretax Income
109.72188.74119.23370.67360.73262.42
Income Tax Expense
7.7117.2310.144.6349.7436.54
Earnings From Continuing Operations
102.01171.5109.13326.04310.99225.88
Minority Interest in Earnings
0.190.13----
Net Income
102.2171.63109.13326.04310.99225.88
Net Income to Common
102.2171.63109.13326.04310.99225.88
Net Income Growth
-37.02%57.28%-66.53%4.84%37.68%98.86%
Shares Outstanding (Basic)
218220221220220178
Shares Outstanding (Diluted)
218220221220220178
Shares Change (YoY)
-1.50%-0.43%0.82%-0.20%23.76%7.82%
EPS (Basic)
0.470.780.491.481.411.27
EPS (Diluted)
0.470.780.491.481.411.27
EPS Growth
-36.06%57.96%-66.80%5.05%11.25%84.44%
Free Cash Flow
103.9100.7763.57110.5797.43133.61
Free Cash Flow Per Share
0.480.460.290.500.440.75
Dividend Per Share
0.2860.5000.4080.1530.7040.656
Dividend Growth
-22.24%22.49%166.62%-78.26%7.33%-
Gross Margin
30.15%32.56%32.17%39.12%44.00%47.07%
Operating Margin
9.48%13.83%11.23%22.07%28.14%32.48%
Profit Margin
9.09%15.39%11.19%22.20%26.04%27.23%
Free Cash Flow Margin
9.24%9.04%6.52%7.53%8.16%16.10%
EBITDA
187.66236.5193.48364.88357.54288.4
EBITDA Margin
16.69%21.21%19.84%24.84%29.94%34.76%
D&A For EBITDA
81.0782.3283.9940.6621.5218.91
EBIT
106.59154.18109.49324.22336.02269.49
EBIT Margin
9.48%13.83%11.23%22.07%28.14%32.48%
Effective Tax Rate
7.03%9.13%8.47%12.04%13.79%13.92%
Revenue as Reported
1,1241,115975.081,4691,194829.65
Advertising Expenses
-4.364.173.5624.1413.83
Source: S&P Global Market Intelligence. Standard template. Financial Sources.